A new study published in the American Journal of Preventive Medicine has revealed that fewer than one in five older adults discuss their cannabis use with clinicians. This communication gap occurs within an increasingly permissive policy landscape, even as seniors' perception of cannabis-related risks continues to decline sharply.
Analyzing data from 14,387 participants in the 2021–2023 National Survey on Drug Use and Health (NSDUH), researchers evaluated substance use alongside healthcare interactions. The findings highlight a significant disconnect between substance prevalence and clinical engagement among older demographics:
- Substance Use: 57.0% of older adults reported past-year alcohol use, 13.0% reported tobacco use, and 8.1% reported cannabis use.
- Screening Gaps: Only 19.2% of older adults discussed cannabis with clinicians, 37.3% underwent cannabis-only screening, and 43.5% experienced no screening or discussion whatsoever.
- Health Vulnerability: More than a third (36.9%) of all surveyed adults reported living with two or more chronic conditions.
Given the heightened health risks associated with substance use in older age, the study's authors emphasize the urgent need for clinical and structural supports. They recommend utilizing brief, two-step assessment tools like the TAPS-2 Tool to help healthcare providers proactively identify and guide discussions around potentially harmful cannabis use.
